跳至主要内容
临床试验/IRCT20210130050179N2
IRCT20210130050179N2招募中2 期

Evaluation of safety and effectiveness of Eczacin cream made by Pharmed Salamat Sina company in improving mild and moderate atopic dermatitis in adults

Sina pharmed salamat0 个研究点目标入组 19 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
19

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Chronic or recurrent eczema with a mild to moderate severity and personal or family history of Atopia or high IgE level
  • Signing the consent form for participation in the study
  • Minimum score of one for the SCORAD (Severity Scoring of Atopic Dermatitis index) scale of redness and itching

排除标准

  • Not to use topical medications for Atopic Dermatitis (except for moisturizer) in the last 2 weeks or systemic medications in the last 4 weeks. Use of steroids or systemic immunosuppressive drugs with any indication.
  • Pregnancy or lactating
  • Severe atopic dermatitis (SCORAD above 12)

研究者

发起方
Sina pharmed salamat

相似试验